yingweiwo

Others 12

Others 12

Others 12 related products

Structure Cat No. Product Name CAS No. Product Description
Monomethyl auristatin E intermediate-12 V59899 Monomethyl auristatin E intermediate-12 870640-61-2 Monomethyl auristatin E intermediate-12 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-13 V59625 Monomethyl auristatin E intermediate-13 870640-64-5 Monomethyl auristatin E intermediate-13 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-14 V59328 Monomethyl auristatin E intermediate-14 1932791-56-4 Monomethyl auristatin E intermediate-14 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-15 ((S)-2 - ((1R,2S)-3-(benzyloxy)-1-hydroxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylic acid ) V59814 Monomethyl auristatin E intermediate-15 ((S)-2 - ((1R,2S)-3-(benzyloxy)-1-hydroxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylic acid ) 173653-47-9 Monomethyl auristatin E intermediate-15 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-16 V59554 Monomethyl auristatin E intermediate-16 2380991-16-0 Monomethyl auristatin E intermediate-16 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-4 V59840 Monomethyl auristatin E intermediate-4 1823777-46-3 Monomethyl auristatin E intermediate-4 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-5 V59440 Monomethyl auristatin E intermediate-5 1822810-13-8 Monomethyl auristatin E intermediate-5 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-6 V59370 Monomethyl auristatin E intermediate-6 135383-54-9 Monomethyl auristatin E intermediate-6 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-7 V59545 Monomethyl auristatin E intermediate-7 135383-55-0 Monomethyl auristatin E intermediate-7 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
Monomethyl auristatin E intermediate-9 V59556 Monomethyl auristatin E intermediate-9 120205-58-5 Monomethyl auristatin E intermediate-9 is an intermediate reactant in the synthesis/preparation of Monomethyl auristatin E.
MOPIPP V62746 MOPIPP 1485521-76-3 MOPIPP is a novel indolyl chalcone, vacuolin-1, a non-lethal vacuole-inducing 2-propyl analog of MOMIPP.
MRGPRX1agonist 4 V61714 MRGPRX1agonist 4 2764889-60-1 MRGPRX1 agonist 4 (compound 1t) is a potent and orally bioactive PAM (positive allosteric modulator) of Mas-related G protein-coupled receptor X1 (MRGPRX1) with EC50 of 0.1 μM.
MrgprX2 antagonist-6 V62207 MrgprX2 antagonist-6 2902573-97-9 MrgprX2 antagonist-6 (compound 9) is an antiallergic agent.
MrgprX2 antagonist-7 V58051 MrgprX2 antagonist-7 2902573-98-0 MrgprX2 antagonist-7 (compound 10) is an antiallergic agent.
MRGPRX4agonist-1 V60298 MRGPRX4agonist-1 2768131-22-0 MRGPRX4 agonist-1 (compound 30d) is a selective agonist of MRGPRX4 with EC50s of 11.2 nM and 30.0 nM in Ca2+ assay and β-arrestin assay, respectively.
MRT-2359 V64195 MRT-2359 2803881-11-8 MRT-2359 is an orally bioavailable GSPT1 degrader with anti-tumor activity.
MRV03-068 V57375 MRV03-068 2797066-30-7 MRV03-068 (compound 2) is a selective colibactin-activated peptidase (ClbP) inhibitor that can block the genotoxic effect of colibactin on eukaryotic cells.
MRV03-069 V58542 MRV03-069 2797066-35-2 MRV03-069 (compound 3) is a selective colibactin-activated peptidase (ClbP) inhibitor that can block the genotoxic effect of colibactin on eukaryotic cells.
MSN8C V57623 MSN8C 1314798-31-6 MSN8C is an analog of mansolone E and a novel catalytic inhibitor of human DNA topoisomerase II.
MTSEA hydrobromide V57487 MTSEA hydrobromide 16599-33-0 MTSEA HBr is a sulfhydryl-reactive compound that modifies free cysteine residues to produce a positively charged side chain comparable in size to lysine.
Contact Us